Enhancement of cardiovascular effects of glucagon by aminophylline.
D000262:Adenylyl Cyclases; D000628:Aminophylline / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D000242:Cyclic AMP / Q000502:physiology; D004285:Dogs; D004357:Drug Synergism; D004790:Enzyme Induction; D005934:Glucagon / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors; D012039:Regional Blood Flow / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects
D010726:Phosphodiesterase Inhibitors; D000628:Aminophylline; D005934:Glucagon; D000242:Cyclic AMP; D000262:Adenylyl Cyclases